User login
- /content/daratumumab-plus-carfilzomib/dexamethasone-effective-lenalidomide-refractory-myeloma
- /hematologynews/article/169342/multiple-myeloma/daratumumab-plus-carfilzomib/dexamethasone-effective
- /oncologypractice/article/169342/multiple-myeloma/daratumumab-plus-carfilzomib/dexamethasone
- /hematology-oncology/article/169342/multiple-myeloma/daratumumab-plus-carfilzomib/dexamethasone